Salesforce Announces Quarterly Dividend
Salesforce Inc (CRM) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and AI-Driven Expansion [Yahoo! Finance]
Salesforce’s Agentforce Life Sciences Selected by AstraZeneca as Its Unified Global Platform to Help Transform Customer Engagement
Salesforce (NYSE:CRM) had its price target raised by analysts at Northland Securities from $264.00 to $267.00. They now have a "market perform" rating on the stock.
Salesforce (NYSE:CRM) had its price target raised by analysts at Macquarie from $250.00 to $265.00. They now have a "neutral" rating on the stock.